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Introduction 
Helicobacter  pylori  (H.  pylori),  is  a  gram  negative 
bacterial species that colonizes the human stomach and 
has  been  associated  with  human  for  at  least  tens  of 
thousands  of  years.
1  This  bacteria  is  permanently 
colonizes gastric epithelial cells in approximately 25% 
of the population in developed countries and 70–90% 
in  developing  countries,  whereas  most  infected 
individuals  are  asymptomatic.  Chronic  H.  pylori 
infection in susceptible individuals is associated with a 
variable degree of mucosal damage ranging from mild 
gastritis  and  ulcer  disease  to  gastric  carcinoma  and 
mucosa-associated  lymphoid  tissue  (MALT) 
lymphoma.
2 Colonization with these bacteria is usually 
without clinical consequences, but increases the risk of 
developing  peptic  ulcer  disease,  gastric 
adenocarcinoma and lymphoma.
3  
The clinical outcome of  H. pylori infection has been 
associated with bacterial virulence factors, host gastric 
mucosal factors, and the environment.
4 It is estimated 
that 50% of the world’s population is infected with H. 
pylori,  but  the  factors  associated  with  different 
outcomes, such as non-ulcer dyspepsia (NUD), peptic 
ulcer  disease  (PUD)  or  gastric  carcinoma,  are 
unknown.
5  This  diverse  clinical  outcome  may  be 
associated with the expression of virulence factors. The 
cytotoxin-associated gene (cagA), which is not present 
in every H. pylori strain, is considered to be a marker 
for the cag pathogenicity island, and its expression is 
associated  with  severe  infection.
6,7  In  contrast,  the 
vacuolating cytotoxin gene (vacA) is present in most H. 
pylori  strains,  although  the  VacA  toxin  may  not  be 
expressed in all cases.
8 The vacA gene contains a signal 
region and a middle region, both of which are divided 
into  two  allelic  types:  s1  or  s2,  and  m1  or  m2, 
respectively. These types are divided into the subtypes 
s1a,  s1b  or  s1c,  and  m2a  or  m2b.  Both  s1/m1  and 
cagA-positive  strains  have  been  reported  to  be 
associated  with  PUD  and  gastric  carcinoma.
9  The 
purpose of this research was to analyze cagA and vacA 
genotypes status in H. pylori isolates. 
 
Materials and Methods 
Patients 
A total of 115 H. pylori isolates were obtained from 
gastric biopsies of patients with gastritis, peptic ulcer 
and  gastroesophageal  reflux  diseases  undergoing 
endoscopy.  This  study  was  approved  by  the  ethical 
committee  of  regional  Medical  Research  of  Tabriz 
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Purpose: The purpose of this research was to analyze cagA and vacA genotypes status 
in H. pylori isolates and relationship with clinical outcomes. Methods: Gastric biopsy 
specimens were cultured for H. pylori isolation and cagA and vacA genes were detected 
in these isolates. Data were collected and the results were analyzed using χ2 and Fishers 
exact tests by SPSS software version. 16. Results: Of the total 115 H. pylori isolates, 79 
(68.7 %) were cagA positive and 82 (71.3%) of isolates contained the s1 allele which 33 
(28.7%) were subtype s2. s1m2 was the most frequent vacA allelic combination in the 
H. pylori isolates examined (63 cases), followed by s2m2 (31 cases), s1m1 (19 cases) 
and s2m1 (2 case). Strains cagA positive were more frequent in peptic ulcer diseases 
patients than non ulcer diseases patients, as 47 (59.5%) and 32 (40.5%), while cagA 
negative were low, as 15 (41.7%) and 21 (58.3%), respectively. Conclusion: We found 
that the cagA and vacA status were not related to clinical outcomes in this area. Overall, 
in the present study, vacA s1/m2, cagA-positive strains were predominant irrespective 
of clinical outcome, but s2/m1 was rare.  
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University  of  Medical  Sciences  and  all  patients 
provided written informed consent for this research. 
 
H. pylori Culture and extraction of Genomic DNA 
Briefly gastric biopsy samples were homogenized and 
cultured onto Brucella agar containing 5% sheep blood 
and  antibiotics  supplements.  Culture  plates  were 
incubated  at  microaerophilic  condition  at  37  ºC  and 
high humidity for 5-7 days. Organisms were identified 
as  H.  pylori  based  on  colony  morphology,  gram 
staining and positive oxidase, catalase and urease tests. 
Genomic DNA of total H. pylori strains was extracted 
by using CTAB
10 and stored at – 20 ºC. Briefly, the 
loop full of bacteria was added to 1.5 ml sterile distilled 
water, vortexed well and was centrifuged in 1000 g for 
10 min. The supernatant was discarded and 270 µl T/E 
buffer plus 30 µl SDS 10% plus 5 µl proteinase K was 
added  to  microtube  and  then  incubated  at  50  ºC 
overnight.  One hundred µl of 5 M NaCl solution was 
added  to  microtube  and  mixed  well.  Eighty  µl  of 
prewarmed CTAB/NaCl (65
 ºC) solution was added to 
microtube and vortexed well. Then the microtube was 
incubated at 65 ºC for 10 minutes.  Seven hundred µl of 
chloroform-isoamylalcohol  (24:1)  solution  was  added 
to  the  microtube  and  vortexed  for  20  second.  The 
suspension was centrifuged at 12000 g for 5-10 minute 
at 10 
oC and aqueous phase was transferred into new 
microtube. Then, 200-300 µl isopropanol was added to 
each microtube and mixed gently, and incubated at -20
 
ºC for 30 minute, finally centrifuged at 12000 g for 10 
min.  The  supernatant  was  discarded  and  pellet  was 
resuspended  in  1  ml  of  70%  cold  ethanol,  and  then 
centrifuged  at  12000g  for  5  min  at  10  ºC.  The 
supernatant  was  discarded  and  after  air  drying,  the 
DNA pellet was dissolved in 50 µl T/E (10:1) buffer 
and incubated at 37
 ºC for 30 min, then stored at 4
 ºC 
overnight. 
 
Detection of cagA and vacA mosaicism distribution 
In  this  study  PCR  was  used  to  detect  the  H.  pylori 
specific  ureC  gene  for  confirmation  of  H.  pylori 
isolates, the virulence-associated vacA mosaic structure 
and the presence of cagA gene. All primer sets were 
selected  from  the  published  literatures  (Table  1).
11,12  
PCR reactions  were  performed  in  a  volume  of  50µL 
containing10mmol/L  Tris-HCl,  1.5mmol/L  MgCl2, 
0.2mmol/L of each deoxynucleotide, 25 pmol of each 
primer  and  2.5  units  of  Taq  polymerase  (Geneone, 
Germany). PCR amplification conditions for cagA and 
glmM genes, involved 3 min of pre incubation at 94ºC, 
followed by 35 cycles of 30 s at 94 ºC, 30 s at 58 ºC, 
and 30 s at 72 ºC and 3min at 72°C for final extension. 
The  vacA  typing  was  performed  with  the  following 
conditions: 3 min for pre incubation at 94 ºC, followed 
by  35  cycles  of  30  s  at  94  ºC,  30  s  at  61  ºC  (for 
m1/m2),  50 ºC (for s1/s2),  44 ºC (for s1a), 52 ºC (for 
s1b)  for  annealing,  and  3  min  at  72°C  for  final 
extension.  PCR  products  were  visualized  by 
electrophoresis  on  1.5%  agarose  gels  with  ethidium 
bromide.  DNA  from  isolates  with  known  genotypes 
was used as a positive control. 
 
Table 1. Primers for amplification used in this study 
DNA region amplified  Primer  Primer sequence  PCR products (bp) 
ureC (glmM) 
HP-F 
HP-R 
GGATAAGCTTTTAGGGGTGTTAGGGG 
GCTTACTTTCTAACACTAACGCGC 
294 
cagA 
cagA-Fm 
cagA-Rm 
AGG GAT AAC AGG CAA GCT TTT GA 
CTG CAA AAG ATT GTT TGG CAG A  352 
vacA-m1 
ml -Fm 
ml -Rm 
GGT CAA AAT GCG GTC ATG G 
CCA TTG GTA CCT GTA GAA AC 
290 
vacA-m2 
m2-Fm 
m2-Rm 
GGA GCC CCA GGA AAC ATT G 
CAT AAC TAG CGC CTT GCA C 
352 
vacA-s1 or s2 
VA1-F 
VA1-R 
ATGGAAATACAACAAACACAC 
CTGCTTGAATGCGCCAAAC  259 or 286 
vacA-s1a 
S1a-Fm 
S1a-Rm 
GTC AGC ATC ACA CCG CAA C 
CTG CTT GAA TGC GCC AAA C 
190 
vacA-s1b 
S1b-Fm 
S1b-Rm 
AGC GCC ATA CCG CAA GAG 
CTG CTT GAA TGC GCC AAA C 
187 
 
Statistics analysis 
Data were analyzed by SPSS version 16. The Pearson 
X
2 test was used to evaluate the relationship between 
individual genotypes and a variety of diseases. Logistic 
regression  analysis  was  used  to  relate  the  different  
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combinations of vacA and cagA genotypes of H. pylori 
to the presence of peptic ulcers.  
 
Results 
Fifty-three of our 115 patients were classified as non-
ulcer diseases and, sixty-two patients had proven peptic 
ulcer disease based on observation during gastroscopy. 
There was no significant difference between the mean 
age  of  patients  with  and  without  ulcers.  By  using 
primers HP-F and HP-R to amplify the ureC gene, the 
expected PCR product of 294-bp was obtained in all 
strain isolates.  Simultaneously  using  specific  primers, 
cagA gene was detected in 79 (68.7 %) isolates. 
In  our  study,  strains  carrying  the  cagA  gene  (cagA-
positive)  were  more  frequent  in  PUD  patients  than 
NUD patients,  as  47  (59.5%) and  32  (40.5%),  while 
strains lacking cagA gene (cagA-negative) were  low, 
as 15 (41.7%) and 21 (58.3%), respectively (Table 2 
and 3).  
In our study the presence of the  vacA gene also was 
investigated  in  all  of  the  isolates  by  PCR.  Complete 
vacA s- and m-region genotypes were obtained in all 
samples.  The  majority  of  them  (82  of  115;  71.3%) 
contained the s1 allele; most of them (80 of 82; 97.5%) 
were subtype s1a, and 2 of 82 (2.4%) were subtype s1b, 
However, 33 of 115 (28.7%) were subtype s2 (Figure 
1). In this study, we did not find s1c. With regard to the 
middle  region  of  115  strains,  21(18%)  samples  were 
positive for the middle regions of the vacA genes (m1) 
and  94  (81.7%)  were  positive  for  the  middle  region 
(m2) by PCR. Meanwhile, PCR product size was 290 
bp and 352 bp for m1 and m2, respectively. 
 
Table 2. Distribution of vacA genotypes among 115 cagA-positive and cagA-negative H. pylori strains 
Genotype 
Number (%) of strains 
Total (115)  Pv 
cagA-positive (n=79)  cagA-negative (n=36) 
s1/m1  19(100%)  0(0%)  19(16.5%)  0.005 
s1/m2  53(84.1%)  10(15.9%)  63(54.8%)  0.001 
s2/m1  0(0%)  2(100%)  2(1.7%)  0.005 
s2/m2  7(22.6%)  24(77.4%)  31(26.9%)  0.001 
 
 
Table 3. Relationship between clinical outcome and status of cagA and vacA genotypes by logistic regression analysis 
Genotypes 
Number (%) of isolates 
Total (n=115)  Pv 
NUD (n=53)  PUD (n=62) 
vacAs1  34(29.6%)  48 (41.7%)  82 (71.3%)  0.5 
vacAs1a  32 (27.8%)  47 (40.9%)  79 (68.7%)  1 
vacAs1b  1(0.9%)  1 (0.9%)  2 (1.8%)  1 
vacAs2  19 (16.5%)  14 (12.2%)  33 (28.7%)  0.1 
vacAm1  7 (6.1%)  14 (12.2%)  21 (18.3%)  0.3 
vacAm2  46 (40%)  48 (41.7%)  94 (81.7%)  0.1 
vacAs1m1  6 (5.2%)  13 (11.3%)  19 (16.5%)  0.1 
vacAs1m2  28 (24.3%)  35 (30.4%)  63 (54.8%)  0.1 
vacAs2m1  1 (0.9%)  1 (0.9%)  2 (1.8%)  0.1 
vacAs2m2  18 (15.7%)  13 (11.3%)  31 (27%)  0.1 
cagA  32 (27.8%)  47 (40.9%)  79 (68.7%)  0.07 
 
Discussion 
The cagA gene is part of a 40 kb DNA insertion that is 
considered to  have  the  typical features  of  a  bacterial 
pathogenicity  island  (PAI)  and  may  have  originated 
from a non- helicobacter source. In the present study, 
68.7% of the patients were infected with cagA-positive 
strains,  similar  to  another  Iranian  study.
13  However, 
this is different from studies from East to South Asian 
countries where more than 90% of the strains carry the 
cagA  gene  regardless  of  clinical  outcomes.
14-16  Our 
result is consistent with studies reported from  Europe 
and  the  USA  where  the  prevalence  of  cagA-positive 
strains is between 60-70%.
9,17  
 60   | 
Ghotaslou et al. 
Advanced Pharmaceutical Bulletin, 2013, 3(1), 57-62  Copyright © 2013 by Tabriz University of Medical Sciences 
 
Figure 1. Amplified products of signal region alleles (S1 
and S2) by PCR 
Lane 1: 100-bp DNA ladder, Lane 2 and 3: S1 genotype  H. 
pylori, Lane 4: S1 positive control of H. pylori, Lane 5 and 6: S2 
genotype  H.  pylori,  Lane  7:  S2  positive  control  of  H.  pylori, 
Lane 8: negative control.   
 
In  this  study,  the  relationship  between  cagA  and 
clinical outcomes was assessed, and although we found 
that 59.5% of PUD and 40.5% of NUD patients were 
infected with cagA-positive strains, while this findings 
was  not  statistically  significant  (Pv  >  0.05).  This 
finding is in agreement with other reports from Iran,
18-
20  but  in  contrast  to  many  studies  from  Western 
countries where  cagA positive strains are more often 
isolated from patients with PUD than with NUD.
21 For 
this difference in the cagA status, one possibility which 
exist is the large genomic variations in the  H. pylori 
genomes  (e.g.,  a  PCR  primer  set)  that  amplifies  the 
cagA gene of H. pylori.
22 There may be several distinct 
forms of the cagA gene with an uneven geographical 
distribution  and  these  differences  in  cagA  genotypes 
may  provide  a  marker  for  differences  in  virulence 
among  cagA-positive  H.  pylori  strains  and  that  only 
some  forms  of  the  cagA  gene  are  associated  with 
severe gastroduodenal diseases.
23 
All strains of H. pylori contain the vacA gene, but they 
vary  in  terms  of  their  ability  to  produce  cytotoxin.
24 
Type s1 and m1 strains demonstrate more toxin activity 
than  s2  and  m2  strains.
11,25  The  vacA  genotypes  are 
significantly  different  in  each  country.  In  Western 
studies,  the  presence  of  vacAs1  and  cagA  has  been 
shown  to  be  significantly  associated  with  peptic 
ulcers.
26 However, several studies in Asian populations 
have  not  confirmed  this  relationship,  indicating  that 
there  are  important  geographic  differences.
15  In  this 
research, the frequency results  of  vacA alleles are  in 
agreement  with  another  study  from  Iran
27  which  was 
reported frequency of s1, s2, m1 and m2 as 69%, 28%, 
31% and 61%, respectively. 
In  our  study,  we  evaluated  the  combination  of  vacA 
gene of different alleles in relation to clinical outcomes 
and  no  statistically  significant  correlation  was  found 
between these alleles and disease conditions (pv>0.05).  
In this study, predominance of s1 and s1m2 genotypes 
of  vacA  was  observed  in  all  clinical  outcomes  in 
patients which is in agreement with other studies from 
Iran which showed s1 allele is associated with PUD, 
including  DU  and  GU  and  also  s1/m2  strain  is 
dominant  genotype  among  infected  Iranian 
patients.
18,19,28-30  Similarly,  s1/m2  genotype  has  been 
found  to  be  predominant  in  Turkey  and  in  Western 
countries.
31  However,  the  vacA  s1/m1  genotype  is 
more predominant from Afghanistan and India.
32,33 
In the present study, we examined the diversity of the 
vacA  gene  and  the  relationship  between  vacA 
genotypes and cagA status with clinical outcomes. The 
vacA s1/m1 genotype was the most virulent genotype, 
although the prevalence was even higher in PUD than 
in NUD patients (13 versus 6), but the differences were 
not statistically significant (Pv > 0.05). The prevalence 
of  the  s2/m2  genotype,  which  is  reported  to  be  less 
virulent, was even lower in PUD than in NUD patients 
(13  versus  18),  but  again  the  difference  was  not 
statistically significant (Pv > 0.05). We also analyzed 
the  signal  region  and  middle  region  separately, 
however,  no  significant  relation  was  found  between 
vacA s and m genotypes and clinical outcomes. There 
are many reports, that s1/m1 genotypes were associated 
with  clinical  outcomes  such  as  PUD,  whereas  s2/m2 
genotypes  were  associated  with  NUD.
34-36  However, 
we  could  not  find  any  relationship  between  vacA 
genotypes and clinical outcomes. We found that s1/m2 
was  the  most  prevalent  genotype  irrespective  of  the 
clinical outcomes. Several studies have been published 
about  the  relationship  between  clinical  outcomes  and 
vacA  and  cagA  status  in  Iranian  populations,
29,30,37,38  
where it has been concluded that the vacA genotypes 
are not a good marker for predicting clinical outcomes. 
In contrast, a study from Shiraz was reported that vacA 
genotypes were significantly different among gastritis, 
PUD and GC patients.
30 In addition, another study from 
Shiraz  reported  that  vacA  genotypes  were  more 
frequently  found  in  PUD  patients  than  in  NUD 
patients;
37 since it is well known that almost all strains 
should  possess  the  vacA  gene,  there  finding  are 
questionable.
37 The clinical relevance of the considered 
virulence-  associated  genes  of  H.  pylori  and 
geographical area is still a subject of controversy. The 
discrepancy  between  these  reports  may  have  several 
causes. First, patient selection is extremely important, 
and  the  study  group  should  be  sufficiently  large  and 
diverse  with  respect  to  genotypes  and  clinical 
symptoms. Second, the PCR assay and typing methods 
used  should  be  adequate  to  determine  the  vacA  and 
cagA genotypes. 
 
Conclusion 
 In  the  present  study  relationship  between  cagA  and 
vacA  genotypes  and  clinical  status  was  not  found, 
which suggest that these genes are not helpful for the 
universal  prediction  of  specific  disease  risk.  Overall, 
we  found  that  vacAs1/m2,  cagA-positive  strains  are 
predominant  in  our  isolates  irrespective  of  clinical 
outcome.  
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